Austar Lifesciences Limited (6118.HK) HKSE

1.03

-0.04(-3.74%)

Updated at September 26 04:08PM

Currency In HKD

Valuation

Market Cap274.41M
Enterprise Value509.56M
P/E Ratio30.12
PEG Ratio0.24
Price/Sales Ratio0.32
Price/Book Ratio0.61
Enterprise/Revenue0.48
Enterprise/EBITDA10.17

Fiscal Year

Fiscal YearDecember 31, 2024
Most Recent QuarterDecember 31, 2024

Profitability

Profit Margin0.01
Operating Margin0.02

Management Effectiveness

Return On Assets0.01
Return On Equity0.02

Income Statement

Revenue1.5B
Revenue/Share2.93
Gross Profit301.22M
EBITDA70.71M
Net Income16.08M
Diluted EPS0.03

Balance Sheet

Total Cash167.81M
Total Cash/Share0.33
Total Debt401.95M
Total Debt/Equity0.51
Current Ratio1.31
Book Value Per Share1.55

Price History

52-Week Change43.06
52-Week High1.97
52-Week Low0.45
Moving Average 50 Days1.31
Moving Average 200 Days0.86

Statistics

Average Volume1.38M
Shares Outstanding512.58M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0
Last Split FactorN/A
Last Split DateN/A